Advance Search

EXPRESSION ANALYSIS OF PHOSPHATASE REGENERATING LIVER-3 (PRL-3) IN OVARIAN CARCINOMA

DOI: https://doi.org/10.20956/nmsj.v1i4.2251
Article History

Submited : August 9, 2017
Published : August 9, 2017

ABSTRACT Introduction: Ovarian carcinoma is the fifth most caused of gynecological death and its incidence has been shaply increased in the last five years. Phosphatase Regenerating Liver-3 (PRL-3) is a protein that play an important role in malignant cell proliferation, differentiation, and motilily. Methods: This study analized PRL-3 protein expression in paraffin block of ovarian carcinoma tissue sections by immunohistochemical analysis using PRl-3 monoclonal antibody. Results: We found that PRL-3 was expressed in all tissues analized. However, statistical testing did not found any relation between PRL-3 expression and clinical stages, also no relation found between PRL-3 expression and histological differentiation degree of ovarian carcinoma. Conclusion: No relation found between PRL-3 expression in early stage and advance stage of ovarian carcinoma, as well as among various degree of histological differentiation. Study using more variable obviously needed to gain the knowledge about the role of PRL-3 in ovarian carcinoma pathogenesis. Keywords: Ovarian carcinoma, Phosphatase Regenerating Liver-3

References

  1. WHO, I.A.F.R.A.C.O. World Cancer Report. In Boyle, P. & Levin, N. (Eds.). Lyon, France,World Health Organization. 2008
  2. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J. & Thun, M. J. Cancer Statistics. CA Can- cer J Clin. 2009; 59: 225-249.
  3. Health Ministry Departement, I. Indonesian Health Profile. Jakarta, Department of Health. 2007
  4. Matter W et al. Role of PRL-3, a Human Muscle-Specific Tyrosine Phosphatase, in Angiotensin-II Signaling. Biochem Biophys Res Commun. 2001; 83: 1061-1068.
  5. Guo K et al. PRL-3 Initiates Tumor Angio- genesis by Recruiting Endothelial Cells In vitro and In vivo. Cancer Research 2006;
  6. -9635.
  8. Faleiro-Rodrigues, C. et al. Association of E-cadherin and β-Catenin Immunoex- pression with Clinicopathologic Features in Primary Ovarian Carcinomas. Human Pathol. 2004; 35(6): 663-69
  9. Fathalla, M. F. Incessant ovulation - a factor in ovarian neoplasia? Lancet. (1971b);2:163-166
  10. Riman, T., Dickman, P. W. & Nilsson, S. Risk factors for invasive epithelial ovarian can- cer: result from a Swedish case-control study. Am J Epidemiol. 2002; 156: 363-373.
  11. Polato F; et al. PRL-3 Phosphatase is Impli- cated in Ovarian Cancer Growth. Clinical Cancer Research. 2005; 11: 6835-6839.
Masadah, R., Maharani, R., & Rauf, S. (2017). EXPRESSION ANALYSIS OF PHOSPHATASE REGENERATING LIVER-3 (PRL-3) IN OVARIAN CARCINOMA. Nusantara Medical Science Journal, 1(4), 139-142. https://doi.org/10.20956/nmsj.v1i4.2251

Downloads

Download data is not yet available.
Fulltext